Human Cervix Cancer Lysates
Pricing |
Normal Lysates: $125/100 ug |
Tumor Lysates: $175/100 ug |
Nor./Tum. set: $270.00 (10% off) |
Discounts |
2-8 Vials 10% |
9-20 Vials 15% |
>20 Vials 20% |
Histologic types of cervical cancer include the following:
Carcinosarcoma (mixed mesodermal sarcomas - 50%), Leiomyosarcoma (30%), Endometrial stromal sarcoma (15%).
The new uterine neoplasm classification of the International Society of Gynecologic Pathologists uses the term carcinosarcoma for all primary uterine neoplasms containing malignant elements of both epithelial and stromal light microscopic appearances, regardless of whether or not malignant heterologous elements are present.
Human Cervix Cancer Lysates | ||||||
Catalog Number |
Diagnosis |
Grade |
Stage |
TNM |
Sex |
Age |
Squamous cell cervical carcinoma |
2 |
II |
T2NxM0 |
F |
21 |
|
Squamous cell cervical carcinoma |
3 |
I |
T1b2NxM0 |
F |
33 |
|
Squamous cell cervical carcinoma |
2 |
I |
T1bNxM0 |
F |
54 |
|
Squamous cell cervical carcinoma |
2 |
I |
T1b2NxM0 |
F |
39 |
|
Squamous cell cervical carcinoma |
1 |
II |
T2NxM0 |
F |
39 |
|
Squamous cell cervical carcinoma |
2 |
I |
T1bNxM0 |
F |
27 |
|
Adenosquamous cell cervical carcinoma |
2 |
I |
T1b2NxM0 |
F |
49 |
|
Squamous cell cervical carcinoma |
1 |
I |
T1b1NxM0 |
F |
32 |
|
Squamous cell cervical carcinoma |
3 |
I |
T1b2NxM0 |
F |
31 |
|
Squamous cell cervical carcinoma |
2 |
I |
T1b2NxM0 |
F |
31 |
|
Squamous cell cervical carcinoma |
2 |
I |
T1b2NxM0 |
F |
47 |
|
Squamous cell cervical carcinoma |
3 |
I |
T1bNxM0 |
F |
46 |
|
Squamous cell cervical carcinoma |
2 |
I |
T1NxM0 |
F |
35 |
|
Adenosquamous cell cervical carcinoma |
2 |
II |
T2N0M0 |
F |
40 |
|
Cervical carcinoma |
n/a |
n/a |
n/a |
F |
53 |
|
Cervical epidermoid carcinoma |
n/a |
n/a |
n/a |
F |
45 |
|
Cervical carcinoma |
n/a |
III |
n/a |
F |
59 |
|
Cervical carcinoma |
n/a |
III |
n/a |
F |
52 |
|
Squamous cell cervical carcinoma |
n/a |
IIa |
n/a |
F |
50 |
|
Adenocarcinoma |
2 |
IIa |
T2N0M0 |
F |
40 |
|
Squamous cell cervical carcinoma |
n/a |
Ia1 |
T1a1N0M0 |
F |
48 |
|
Squamous cell cervical carcinoma |
2 |
IIa |
T2aN0M0 |
F |
44 |
|
Squamous cell cervical carcinoma |
2 |
IIIb |
T1N1M0 |
F |
49 |
|
Squamous cell cervical carcinoma |
1 |
IIIb |
T2N1M0 |
F |
44 |
|
Squamous cell cervical carcinoma |
3 |
I |
T1bNxM0 |
F |
46 |
|
Adenosquamous cell cervical carcinoma |
3 |
I |
T1b2NxM0 |
F |
45 |
|
Squamous cell cervical carcinoma |
2 |
I |
T1b2NxM0 |
F |
53 |
References:
Silverberg SG, Major FJ, Blessing JA, et al.: Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9 (1): 1-19, 1990.